VBI Vaccines Inc. - Special Call Transcript

Apr 25, 2019 / 12:30PM GMT
Operator

Good morning, everyone. Thank you for standing by, and welcome to the VBI Vaccines Pipeline Update Conference Call. (Operator Instructions) As a reminder, this conference call will be recorded.

I'd now like to turn the conference over to Nell Beattie, Chief Business Officer at VBI Vaccines. Please go ahead.

Nell Beattie - VBI Vaccines Inc. - Chief Business Officer

Great. Thank you, and thank you all for joining us this morning as we provide additional detail on the advancement in the Part B of the Phase I/IIa clinical study of VBI-1901, our GBM immunotherapeutic as we announced earlier this week as well as an update on our 2 hepatitis B programs. Joining me on the call this morning from VBI are Jeff Baxter, President and CEO; Dr. David Anderson, Chief Scientific Officer; and Dr. Francisco Diaz-Mitoma, our Chief Medical Officer.

We do also have slides to accompany this call, which you can access through the webcast portal or by going to Investor page of our website under the Events/Presentation section.

Before we begin, I would like

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot